Markus Meyer Selected Research

Creatinine

11/2013	High dose intracoronary N-acetylcysteine in a porcine model of ST-elevation myocardial infarction.
12/2006	Haemodynamic and clinical effects of ularitide in decompensated heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Markus Meyer Research Topics

Disease

20	Heart Failure 01/2024 - 09/2005
9	Atrial Fibrillation 01/2024 - 11/2021
4	Neoplasms (Cancer) 01/2023 - 05/2005
4	Type 2 Diabetes Mellitus (MODY) 01/2018 - 04/2006
3	Myocardial Infarction 02/2022 - 11/2013
3	Body Weight (Weight, Body) 11/2021 - 04/2006
3	Ischemia 11/2013 - 06/2003
2	Fibrosis (Cirrhosis) 12/2022 - 11/2021
2	Cardiac Arrhythmias (Arrythmia) 10/2022 - 02/2022
2	Stroke (Strokes) 02/2022 - 01/2020
2	COVID-19 01/2022 - 08/2020
2	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021 - 01/2018
2	Hypertension (High Blood Pressure) 11/2017 - 11/2012
2	Inflammation (Inflammations) 04/2015 - 11/2010
2	Dyslipidemias (Dyslipidemia) 01/2011 - 08/2006
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2022
1	Tachycardia (Tachyarrhythmias) 10/2022
1	Critical Illness (Critically Ill) 01/2022
1	Ascites 11/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2021
1	Left Ventricular Dysfunction 10/2019
1	Squamous Cell Carcinoma of Head and Neck 05/2018
1	Diabetes Mellitus 11/2017
1	Heart Diseases (Heart Disease) 08/2017
1	Infarction (Infarctions) 11/2013
1	ST Elevation Myocardial Infarction 11/2013
1	Thalassemia 08/2013
1	Ventricular Remodeling 11/2012
1	Anemia 01/2012
1	Pheochromocytoma 05/2011
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 05/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2011
1	Insulin Resistance 01/2011
1	Hypoxia (Hypoxemia) 11/2010
1	Vascular System Injuries 11/2010
1	Atherosclerosis 11/2010

Drug/Important Bio-Agent (IBA)

9	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2024 - 04/2015
6	Natriuretic PeptidesIBA 01/2024 - 12/2005
6	UlaritideIBA 11/2021 - 06/2003
4	pro-brain natriuretic peptide (1-76)IBA 12/2023 - 10/2019
4	Biomarkers (Surrogate Marker)IBA 11/2021 - 09/2007
3	CalciumIBA 08/2017 - 04/2002
2	Monoclonal AntibodiesIBA 01/2023 - 12/2022
2	Claudin-1IBA 01/2023 - 12/2022
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 02/2022 - 01/2022
2	DiureticsIBA 11/2021 - 12/2006
2	Adenosine Triphosphatases (ATPase)IBA 01/2021 - 09/2005
2	phospholambanIBA 01/2021 - 09/2005
2	Myosins (Myosin)IBA 01/2020 - 11/2012
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 04/2006
2	CreatinineIBA 11/2013 - 12/2006
2	Insulin (Novolin)FDA Link 02/2008 - 04/2006
2	Peptides (Polypeptides)IBA 02/2008 - 01/2003
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2023
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2023
1	EpitopesIBA 12/2022
1	4-boronic acid benzophenoneIBA 10/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Hormones (Hormone)IBA 11/2021
1	Bromhexine (Bisolvon)IBA 08/2020
1	Adenosine Diphosphate (ADP)IBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Mineralocorticoid Receptor AntagonistsIBA 12/2019
1	Spironolactone (Aldactone)FDA LinkGeneric 12/2019
1	Trifluoperazine (Stelazine)FDA LinkGeneric 05/2018
1	ThapsigarginIBA 05/2018
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 05/2018
1	Small Interfering RNA (siRNA)IBA 05/2018
1	IvabradineIBA 01/2018
1	Advanced Glycation End ProductsIBA 11/2017
1	Tissue Inhibitor of Metalloproteinase-1IBA 04/2015
1	ConnectinIBA 04/2015
1	Fibrillar CollagensIBA 04/2015
1	CollagenIBA 04/2015
1	C-Reactive ProteinIBA 04/2015
1	Acetylcysteine (Siran)FDA LinkGeneric 11/2013
1	Contrast MediaIBA 11/2013
1	Phosphotransferases (Kinase)IBA 11/2013
1	TroponinIBA 11/2013
1	hemoglobin A2'IBA 08/2013
1	Hemoglobins (Hemoglobin)IBA 08/2013
1	Erythropoietin FDA Link 01/2012
1	Propranolol (Inderal)FDA LinkGeneric 05/2011
1	aleglitazarIBA 01/2011
1	LipidsIBA 01/2011
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2011
1	Mercaptoethanol (2 Mercaptoethanol)IBA 11/2010
1	2-MethoxyestradiolIBA 11/2010
1	Estradiol (Delestrogen)FDA LinkGeneric 11/2010
1	CholesterolIBA 11/2010
1	BAY 58-2667IBA 12/2009
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 12/2009
1	Soluble Guanylyl CyclaseIBA 12/2009

Therapy/Procedure

7	Therapeutics 12/2023 - 06/2003
1	Drug Therapy (Chemotherapy) 11/2021
1	Personal Protective Equipment 08/2021
1	Ligation 11/2013
1	Catheters 11/2013
1	Glycemic Control 01/2011